379 related articles for article (PubMed ID: 16262750)
1. Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty.
Farrugia A; Ironside JW; Giangrande P
Vox Sang; 2005 Nov; 89(4):186-92. PubMed ID: 16262750
[TBL] [Abstract][Full Text] [Related]
2. Current strategies to prevent transmission of prions by human plasma derivatives.
Burnouf T; Padilla A
Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
[TBL] [Abstract][Full Text] [Related]
3. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
Ludlam CA; Turner ML
Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
[TBL] [Abstract][Full Text] [Related]
4. [The risk of variant Creutzfeldt-Jakob disease in the Netherlands and the effect of preventive measures].
Kersseboom R; Koekoek SC; Richardus JH
Ned Tijdschr Geneeskd; 2002 Apr; 146(16):754-9. PubMed ID: 11998352
[TBL] [Abstract][Full Text] [Related]
5. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
Flan B; Arrabal S
Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
[TBL] [Abstract][Full Text] [Related]
6. The risk of accidental transmission of transmissible spongiform encephalopathy: identification of emerging issues.
Ramasamy I
Public Health; 2004 Sep; 118(6):409-20. PubMed ID: 15313594
[TBL] [Abstract][Full Text] [Related]
7. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
Turner ML; Ludlam CA
Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
[TBL] [Abstract][Full Text] [Related]
8. [Spongiform encephalopathies].
Pastoret PP
Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):25-38. PubMed ID: 9868830
[TBL] [Abstract][Full Text] [Related]
9. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
Ironside JW; Head MW
Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
[TBL] [Abstract][Full Text] [Related]
10. Impact of vCJD on blood supply.
Seitz R; von Auer F; Blümel J; Burger R; Buschmann A; Dietz K; Heiden M; Hitzler WE; Klamm H; Kreil T; Kretzschmar H; Nübling M; Offergeld R; Pauli G; Schottstedt V; Volkers P; Zerr I
Biologicals; 2007 Apr; 35(2):79-97. PubMed ID: 17320412
[TBL] [Abstract][Full Text] [Related]
11. [Bovine spongiform encephalopathy in ruminants and the new variant of Creutzfeldt-Jakob disease in humans].
Groschup MH
Dtsch Tierarztl Wochenschr; 1999 Aug; 106(8):329-31. PubMed ID: 10488637
[TBL] [Abstract][Full Text] [Related]
12. Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood.
Gregori L; Yang H; Anderson S
Transfusion; 2011 Dec; 51(12):2596-602. PubMed ID: 21645006
[TBL] [Abstract][Full Text] [Related]
13. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
van Aken WG
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1444-7. PubMed ID: 11503311
[TBL] [Abstract][Full Text] [Related]
14. [Confusion surrounding bovine spongiform encephalopathy (BSE) and the risk of new variant Creutzfeldt Jakob disease].
Zaaijer HL
Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2288-90. PubMed ID: 11143292
[TBL] [Abstract][Full Text] [Related]
15. [Prion disease as infectious disease transmissible from animals to human].
Horiuchi M
Nihon Rinsho; 2005 Dec; 63(12):2213-20. PubMed ID: 16363697
[TBL] [Abstract][Full Text] [Related]
16. Risk of variant Creuzfeldt-Jakob disease from factor concentrates: current perspectives.
Farrugia A
Haemophilia; 2002 May; 8(3):230-5. PubMed ID: 12010416
[TBL] [Abstract][Full Text] [Related]
17. Bovine sera used in the manufacture of biologicals: current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies.
Asher DM
Dev Biol Stand; 1999; 99():41-4. PubMed ID: 10404874
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of bovine spongiform encephalopathy.
MacKnight C
Clin Infect Dis; 2001 Jun; 32(12):1726-31. PubMed ID: 11360215
[TBL] [Abstract][Full Text] [Related]
19. [Transmissible spongiform encephalopathies--illnesses in the human].
Budka H
Wien Med Wochenschr; 1998; 148(4):86-95. PubMed ID: 9611348
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health.
Lasmézas CI; Fournier JG; Nouvel V; Boe H; Marcé D; Lamoury F; Kopp N; Hauw JJ; Ironside J; Bruce M; Dormont D; Deslys JP
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4142-7. PubMed ID: 11259641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
